AXXAM

Hit & Lead Discovery

At Axxam, we understand that the road to success in drug discovery is paved with challenges. Hence, our commitment to excellence begins with well-defined and meticulously planned hit identification and hit-to-lead campaigns. These processes seamlessly integrate the efforts of multidisciplinary teams, involving biologists, medicinal chemists, engineers, and data analysts and combining their diverse skills and know-how.  

The central theme is the pursuit of quality. In our view, combining superior assay sensitivity with robust and reproducible test performance is key to identifying the most promising hit compounds to be promoted through the hit-to-lead phase. 

Learn more about our capabilities in hit and lead identification, as well as our screening platforms.

Scroll to Top